Revance Therapeutics has filed a patent for a method to generate a user interface for a subscription management system. The method involves receiving order data for different subscription offerings, combining the data into a subscription structure, calculating payment amounts, and presenting them in the user interface. The system also includes a financial checkout process that allows users to select financing offers and complete the transaction in real time. GlobalData’s report on Revance Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

According to GlobalData’s company profile on Revance Therapeutics, nanoparticle drug conjugates was a key innovation area identified from patents. Revance Therapeutics's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.

A patent filed for a subscription management system user interface

Source: United States Patent and Trademark Office(USPTO). Credit: Revance Therapeutics Inc

A recently filed patent (Publication Number: US20230153772A1) describes a system that enables the dynamic creation of a financial data structure for a bundle of offerings and facilitates a financial checkout process in real time. The system includes one or more processors and memories, along with a set of instructions that configure the processors to perform various operations.

The system receives first order data via a user interface, which relates to the first offering of a bundle of offerings. This data includes a set of attributes and is presented in a matrix format. It also receives second order data related to a second offering of the bundle, including a second set of attributes. Based on a user's selection of a combined one-time payment or a combined monthly subscription payment, the system dynamically creates a financial data structure and uses it to request financing offers from financial exchanges.

Once the system receives the financing offers, it facilitates a financial checkout process in real time. This process includes applying a rule to select a financing offer from the available options, which can be accepted or rejected via the user interface. The system also allows for the presentation of a one-time payment amount for a third offering that only has a one-time payment option, alongside the combined one-time payment and subscription payment amounts.

The system further includes features such as presenting financing offers received from financial exchange systems, using slider sub-interfaces in an overlaid manner over the matrix to receive input data for the attributes, and a toggle feature that allows users to switch between the presentation of one-time payment and monthly subscription payment amounts.

In summary, this patent describes a system that enables the creation of a financial data structure for a bundle of offerings and facilitates a real-time financial checkout process. It provides flexibility in payment options and allows for the presentation of financing offers from financial exchanges. The system also includes user-friendly features such as slider sub-interfaces and a toggle feature for easy navigation and selection of payment options.

To know more about GlobalData’s detailed insights on Revance Therapeutics, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies